Cargando…

Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints

SIMPLE SUMMARY: Cancer treatment mostly involves drugs that has many side effects. In order to limit the toxicity of the chemical drugs, the scientific community embraced immunotherapy involving therapeutic antibodies targeting the tumor. In particular, immunotherapy aims to bolster the immune cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dulal, Dharmindra, Boring, Andrew, Terrero, David, Johnson, Tiffany, Tiwari, Amit K., Raman, Dayanidhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216651/ https://www.ncbi.nlm.nih.gov/pubmed/37345111 http://dx.doi.org/10.3390/cancers15102774

Ejemplares similares

Identification of Cardiac Glycosides as Novel Inhibitors of eIF4A1-Mediated Translation in Triple-Negative Breast Cancer Cells
por: Howard, Cory M., et al.
Publicado: (2020)

Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
por: Sridharan, Sangita, et al.
Publicado: (2019)

Role of eIF4A1 in triple‐negative breast cancer stem‐like cell‐mediated drug resistance
por: Raman, Dayanidhi, et al.
Publicado: (2020)

Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes
por: Zajac, Kelsee K., et al.
Publicado: (2023)

Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes
por: Raman, Dayanidhi, et al.
Publicado: (2020)

Alternative Checkpoints as Targets for Immunotherapy
por: Pant, Ayush, et al.
Publicado: (2020)

Immune Checkpoints: Therapeutic Targets for Pituitary Tumors
por: Nie, Ding, et al.
Publicado: (2021)

New and alternative approaches to tackling antibiotic resistance
por: Tillotson, Glenn S., et al.
Publicado: (2013)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023)

Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
por: Sridharan, Sangita, et al.
Publicado: (2019)

Hyperthermia Targeting the Tumor Microenvironment Facilitates Immune Checkpoint Inhibitors
por: Li, Zihui, et al.
Publicado: (2020)

Galectin-3: an immune checkpoint target for musculoskeletal tumor patients
por: Nakajima, Kosei, et al.
Publicado: (2020)

Tackling Rapid Radiations With Targeted Sequencing
por: Larridon, Isabel, et al.
Publicado: (2020)

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
por: Cellini, Alessandro, et al.
Publicado: (2023)

Infectious Disease: Tackling Innate Immunity
por: Potera, Carol
Publicado: (2004)

Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
por: Das, Satya, et al.
Publicado: (2019)

Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
por: Efremova, Mirjana, et al.
Publicado: (2018)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
por: Gravbrot, Nicholas, et al.
Publicado: (2019)

Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
por: Yu, Sheng, et al.
Publicado: (2021)

The future of immune checkpoint combinations with tumor-targeted small molecule drugs
por: Sceneay, Jaclyn, et al.
Publicado: (2021)

Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
por: Tang, Tianyu, et al.
Publicado: (2021)

New Frontiers for the Cytoskeletal Protein LASP1
por: Butt, Elke, et al.
Publicado: (2018)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Rotman, Galit, et al.
Publicado: (2013)

A Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells
por: Tukaramrao, Diwakar Bastihalli, et al.
Publicado: (2021)

Immune Checkpoints as Therapeutic Targets in Autoimmunity
por: Paluch, Christopher, et al.
Publicado: (2018)

Targeting immune checkpoints in malignant glioma
por: Zhang, Xuhao, et al.
Publicado: (2016)

Targeting immune checkpoints in hematological malignancies
por: Salik, Basit, et al.
Publicado: (2020)

Targeting phosphatidylserine synergizes with immune checkpoint blockade by inducing de novo tumor specific immunity
por: Huang, Xianming, et al.
Publicado: (2015)

Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy
por: Huang, Xing, et al.
Publicado: (2020)

Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes
por: Cocco, Claudia, et al.
Publicado: (2021)

Schistosoma japonicum EKLF/KLF1 is a potential immune target to tackle schistosomiasis
por: Piao, Xianyu, et al.
Publicado: (2023)

Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
por: Crittenden, Marka R., et al.
Publicado: (2018)

Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer
por: Liebler, Daniel C., et al.
Publicado: (2020)

TACkling Cancer by Targeting Selective Protein Degradation
por: Noblejas-López, María del Mar, et al.
Publicado: (2023)

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
por: Koyama, Shohei, et al.
Publicado: (2016)

A real‐world data of Immune checkpoint inhibitors in solid tumors from India
por: Noronha, Vanita, et al.
Publicado: (2021)

Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth
por: Rawangkan, Anchalee, et al.
Publicado: (2018)

Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018)

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
por: Zemek, Rachael M., et al.
Publicado: (2020)

The roles of exosomal immune checkpoint proteins in tumors
por: Xing, Cheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1fplcorc8v2ubeo2s8qp7j7end